Cargando…

Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies

BACKGROUND: Calprotectin is a marker of inflammation, but its clinical utility in dogs with chronic inflammatory enteropathies (CIE) is unknown. OBJECTIVE: Evaluation of fecal calprotectin in dogs with biopsy‐confirmed CIE. ANIMALS: 127 dogs. METHODS: Prospective case‐control study. Dogs were assign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heilmann, Romy M., Berghoff, Nora, Mansell, Joanne, Grützner, Niels, Parnell, Nolie K., Gurtner, Corinne, Suchodolski, Jan S., Steiner, Jörg M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866976/ https://www.ncbi.nlm.nih.gov/pubmed/29460444 http://dx.doi.org/10.1111/jvim.15065

Ejemplares similares

Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies
por: Heilmann, Romy M., et al.
Publicado: (2017)

Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs
por: Heilmann, Romy M., et al.
Publicado: (2018)

Influence of Breed Size, Age, Fecal Quality, and Enteropathogen Shedding on Fecal Calprotectin and Immunoglobulin A Concentrations in Puppies During the Weaning Period
por: Grellet, A., et al.
Publicado: (2016)

Fecal short‐chain fatty acid concentrations and dysbiosis in dogs with chronic enteropathy
por: Minamoto, Yasushi, et al.
Publicado: (2019)

Association of serum calprotectin (S100A8/A9) concentrations and idiopathic hyperlipidemia in Miniature Schnauzers
por: Heilmann, Romy M., et al.
Publicado: (2019)

Oral Cobalamin Supplementation in Dogs with Chronic Enteropathies and Hypocobalaminemia
por: Toresson, L., et al.
Publicado: (2016)

Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease
por: Otoni, Cristiane C., et al.
Publicado: (2018)

Associations among serum insulin, calprotectin, and C‐reactive protein concentrations in Miniature Schnauzers with idiopathic hyperlipidemia before and after feeding an ultra‐low‐fat diet
por: Xenoulis, Panagiotis G., et al.
Publicado: (2022)

Effect of an extruded animal protein‐free diet on fecal microbiota of dogs with food‐responsive enteropathy
por: Bresciani, Francesca, et al.
Publicado: (2018)

Review of cobalamin status and disorders of cobalamin metabolism in dogs
por: Kather, Stefanie, et al.
Publicado: (2019)

Diagnostic value of fecal cultures in dogs with chronic diarrhea
por: Werner, Melanie, et al.
Publicado: (2020)

Longitudinal assessment of microbial dysbiosis, fecal unconjugated bile acid concentrations, and disease activity in dogs with steroid‐responsive chronic inflammatory enteropathy
por: Guard, Blake C., et al.
Publicado: (2019)

Effect of oral or injectable supplementation with cobalamin in dogs with hypocobalaminemia caused by chronic enteropathy or exocrine pancreatic insufficiency
por: Chang, Chee‐Hoon, et al.
Publicado: (2022)

Serum cobalamin and methylmalonic acid concentrations in juvenile dogs with parvoviral enteritis or other acute enteropathies
por: Hung, Michael, et al.
Publicado: (2023)

Long‐term impact of tylosin on fecal microbiota and fecal bile acids of healthy dogs
por: Manchester, Alison C., et al.
Publicado: (2019)

Fecal acute phase proteins in cats with chronic enteropathies
por: Karra, Dimitra A., et al.
Publicado: (2023)

Association of fecal and serum microRNA profiles with gastrointestinal cancer and chronic inflammatory enteropathy in dogs
por: Lyngby, Janne G., et al.
Publicado: (2022)

Comparison of intestinal expression of the apical sodium‐dependent bile acid transporter between dogs with and without chronic inflammatory enteropathy
por: Giaretta, Paula R., et al.
Publicado: (2018)

Effects of metronidazole on the fecal microbiome and metabolome in healthy dogs
por: Pilla, Rachel, et al.
Publicado: (2020)

Fecal Calprotectin Concentrations in Cats with Chronic Enteropathies
por: Riggers, Denise S., et al.
Publicado: (2023)

Ultrasonographic features and prevalence of presumed gastric wall edema in dogs with hypoalbuminemia
por: Murakami, Masahiro, et al.
Publicado: (2020)

Comprehensive comparison of upper and lower endoscopic small intestinal biopsy in cats with chronic enteropathy
por: Chow, Betty, et al.
Publicado: (2020)

Serum proteome of dogs with chronic enteropathy
por: Yu, Jane, et al.
Publicado: (2023)

Clinical utility of an immunoglobulin A‐based serological panel for the diagnosis of chronic enteropathy in dogs
por: Langlois, Daniel K., et al.
Publicado: (2023)

Clinical evaluation and microbiota analysis in 9 dogs with antibiotic‐responsive enteropathy: A prospective comparison study
por: Bottero, Enrico, et al.
Publicado: (2022)

Serum metabolomic profiles in dogs with chronic enteropathy
por: Walker, Hannah K., et al.
Publicado: (2022)

Ultrasonographic features of presumed gastric wall edema in 14 dogs with pancreatitis
por: Murakami, Masahiro, et al.
Publicado: (2019)

Hyperhomocysteinemia in Greyhounds and its Association with Hypofolatemia and Other Clinicopathologic Variables
por: Heilmann, R.M., et al.
Publicado: (2016)

Serum triglyceride and cholesterol concentrations and lipoprotein profiles in dogs with naturally occurring pancreatitis and healthy control dogs
por: Xenoulis, Panagiotis G., et al.
Publicado: (2020)

Narrative review of therapies for chronic enteropathies in dogs and cats
por: Makielski, Kelly, et al.
Publicado: (2018)

Association of chronic enteropathy activity index, blood urea concentration, and risk of death in dogs with protein‐losing enteropathy
por: Kathrani, Aarti, et al.
Publicado: (2019)

Differentiation of lymphocytic‐plasmacytic enteropathy and small cell lymphoma in cats using histology‐guided mass spectrometry
por: Marsilio, Sina, et al.
Publicado: (2020)

Effect of esomeprazole with and without a probiotic on fecal dysbiosis, intestinal inflammation, and fecal short‐chain fatty acid concentrations in healthy dogs
por: McAtee, Rae, et al.
Publicado: (2023)

Clinical characteristics of dogs with food‐responsive protein‐losing enteropathy
por: Nagata, Noriyuki, et al.
Publicado: (2020)

Hypercoagulability in dogs with chronic enteropathy and association with serum albumin concentration
por: Dixon, Amy, et al.
Publicado: (2021)

Pre‐illness dietary risk factors in dogs with chronic enteropathy
por: Trewin, Isla, et al.
Publicado: (2023)

Determining optimal therapy of dogs with chronic enteropathy by measurement of serum citrulline
por: Gerou‐Ferriani, Magda, et al.
Publicado: (2018)

Alterations in serum amino acid concentrations in dogs with protein‐losing enteropathy
por: Kathrani, Aarti, et al.
Publicado: (2018)

Diagnostic features, treatment, and outcome of dogs with inflammatory protein‐losing enteropathy
por: Salavati Schmitz, Silke, et al.
Publicado: (2019)

Coagulation status, fibrinolysis, and platelet dynamics in dogs with chronic inflammatory enteropathy
por: Wennogle, Sara A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bjpvcal00esoctji2v0ekqa0gj